BiorXiv, February 2024
GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression
Dilan Athauda, James R Evans, Laura Mahoney-Sanchez, Gurvir S Virdi, Patricia Lopez-Garcia, Anna Wernick, Aaron Wagen, Karishma D’Sa, Joanne Lachica, Stephanie Strohbuecker, Giulia Vecchi, Craig Leighton, Rebecca S. Saleeb, Judi O’Shaughnessy, Christina E. Toomey, Nirosen Vijiaratnam, Christine Girges, Yazhou Li, Maja Mustapic, Khalida Ismail, Melanie Davies, Dimitrios Kapogiannis, Minee L Choi, Mina Ryten, Mathew H. Horrocks, Nigel Greig, Thomas Foltynie, Sonia Gandhi